Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Enveric Biosciences, Inc. - Common Stock
(NQ:
ENVB
)
1.470
+0.020 (+1.38%)
Delayed Quote
Updated: 3:59 PM EDT, Oct 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Enveric Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q2 2024
↗
August 12, 2024
ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Enveric Biosciences Reports Second Quarter 2024 Financial and Corporate Results
August 12, 2024
From
Enveric Biosciences
Via
Business Wire
Why Is Imunon (IMNN) Stock Up 259% Today?
↗
July 30, 2024
Imunon stock is up on Tuesday with heavy trading of IMNN shares after posting positive results from a Phase 2 clinical trial.
Via
InvestorPlace
Why Is Ekso Bionics (EKSO) Stock Down 15% Today?
↗
July 30, 2024
Ekso Bionics stock is down on Tuesday as investors in the company react to its lackluster earnings report for the second quarter of the year.
Via
InvestorPlace
Why Is Enveric Biosciences (ENVB) Stock Up 18% Today?
↗
July 30, 2024
Enveric Biosciences stock is up on Tuesday with heavy trading of ENVB shares despite a lack of news from the company this morning.
Via
InvestorPlace
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
July 30, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
July 30, 2024
Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!
Via
InvestorPlace
Why F5 Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket
↗
July 30, 2024
Via
Benzinga
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally
↗
July 25, 2024
Via
Benzinga
Enveric Biosciences Announces Preclinical Results Confirming Potential of EB-003 to be Dosed Orally
July 25, 2024
From
Enveric Biosciences
Via
Business Wire
Aries Science & Technology and Enveric Biosciences Announce Licensing Agreement
July 15, 2024
From
Enveric Biosciences
Via
Business Wire
New Patented Psychedelic Drug Brings Hope For Brain Disorder Therapies
↗
July 11, 2024
Enveric Biosciences has been granted a U.S. patent for EB-002, enhancing protection for treatments targeting brain neurological disorders, including depression and anxiety.
Via
Benzinga
Topics
Intellectual Property
Enveric Biosciences Announces Patent Granted for Drug Candidate
July 10, 2024
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate
June 25, 2024
From
Enveric Biosciences
Via
Business Wire
Enveric Biosciences to Participate in BIO International Convention 2024
May 30, 2024
From
Enveric Biosciences
Via
Business Wire
ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q1 2024
↗
May 20, 2024
ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
'Psychedelics-Inspired' Meds For Depression, Anxiety, Addiction Producer Trims Q1 Net Loss YoY, Increases Cash On Hand
↗
May 16, 2024
Enveric Biosciences reported on Wednesday financial results for the first quarter of 2024 ended March 31, 2024."We believe the first quarter of 2024 was a highly productive period for Enveric as the...
Via
Benzinga
Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results
May 15, 2024
From
Enveric Biosciences
Via
Business Wire
Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate
↗
May 14, 2024
Via
Benzinga
Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
May 14, 2024
From
Enveric Biosciences
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
May 08, 2024
Via
Benzinga
Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods
↗
May 08, 2024
The news of the licensee deal comes on the heels of the DEA's move to reschedule marijuana, one source of cannabinoids, as a Schedule III controlled substance.
Via
Benzinga
Topics
Cannabis
Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
May 08, 2024
From
Enveric Biosciences
Via
Business Wire
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
↗
April 17, 2024
Via
Benzinga
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
April 03, 2024
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
April 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 02, 2024
Via
Benzinga
ENVB Stock Earnings: Enveric Biosciences Beats EPS for Q4 2023
↗
April 01, 2024
ENVB stock results show that Enveric Biosciences beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
↗
March 29, 2024
Via
Benzinga
Enveric Biosciences Optimistic On Q4 And Full-Year Results: 'Psychedelic-Inspired' Meds For Future Growth
↗
March 27, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
